Table 3.
Study Group | Basal | 3h Post RE | 6h Post RE |
---|---|---|---|
LAT1/SLC7A5 mRNA, Fold Change | |||
RE+EAA | 1.11 ± 0.23 | 3.95 ± 0.75* | 3.74 ± 0.86*# |
RE | 1.01 ± 0.16 | 2.64 ± 0.49* | 1.84 ± 0.35 |
SNAT2/SLC38A2 mRNA, Fold Change | |||
RE+EAA | 1.04 ± 0.13 | 1.96 ± 0.39* | 1.21 ± 0.37 |
RE | 1.23 ± 0.35 | 1.54 ± 0.18 | 1.19 ± 0.32 |
PAT1/SLC36A1 mRNA, Fold Change | |||
RE+EAA | 1.13 ± 0.21 | 1.66 ± 0.49 | 2.00 ± 0.72‡ |
RE | 1.02 ± 0.22 | 1.01 ± 0.20 | 2.22 ± 0.48 |
CAT1/SLC7A1 mRNA, Fold Change | |||
RE+EAA | 1.12 ± 0.19 | 1.61 ± 0.29 | 3.88 ± 0.93* |
RE | 1.27 ± 0.19 | 1.85 ± 0.20 | 4.84 ± 1.09* |
CD98/SLC3A2 mRNA, Fold Change | |||
RE+EAA | 1.08 ± 0.20 | 1.48 ± 0.42 | 1.68 ± 0.42‡ |
RE | 1.20 ± 0.24 | 0.91 ± 0.12 | 1.89 ± 0.37‡ |
LAT1 Protein, Fold Change | |||
RE+EAA | 1.00 | 0.84 ± 0.09* | 0.96 ± 0.12 |
RE | 1.00 | 1.12 ± 0.07# | 1.25 ± 0.07*# |
SNAT2 Protein, Fold Change | |||
RE+EAA | 1.00 | 1.40 ± 0.11*# | 1.63 ± 0.22*# |
RE | 1.00 | 1.01 ± 0.01 | 1.01 ± 0.01 |
Data are mean±SE. RE+EAA = resistance exercise followed by ingestion of 20 g of essential amino acids 1h following exercise; RE = resistance exercise without EAA ingestion. RE+EAA, n = 6; RE, n = 8.
Significant change from basal (p<0.05);
Significant group difference (p<0.05);
Significant time effect vs. basal (p<0.05).